![]() Credit: Bayer AG.īayer recorded revenues of €39.58bn ($45.27bn), with the combined revenue of the pharmaceuticals, consumer health, and animal health divisions amounting to $27.1bn. Bayer AG – 2.84% Pharmaceuticals division was a major driver for Bayer’s sales growth in 2018. Established in 1876, Eli Lilly and Co is a US-based pharmaceutical company focused on oncology, bio-medicines, and diabetes. The acquisition was intended to strengthen the company’s oncology portfolio of precision drugs. The rise in revenues was primarily due to an increase in volume growth achieved from new pharmaceutical products Trulicity, Taltz, and Basaglar.Įli Lilly completed the acquisition of Loxo Oncology for $8bn in February 2019. Sales in the US increased by 8% to total $13.87bn, while revenues in markets outside the US rose by 6% to $10.68bn. ![]() Eli Lilly and Co – 2.57% Eli Lilly has the biggest market share in the pharmaceutical industry.Įli Lilly’s revenues in 2018 increased by 7% compared to the previous year to reach $24.55bn, with the majority coming from the US.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |